Preview

HIV Infection and Immunosuppressive Disorders

Advanced search

Changes in intestinal flora depending on the stage of HIV infection, viral load and CD4-cell count

https://doi.org/10.22328/2077-9828-2026-18-1-37-43

Abstract

The aim of the work is to establish patterns of changes in the taxonomic composition and functional activity of the intestinal microbiota depending on the clinical stage of HIV infection, the level of viral load and the number of CD4-lymphocytes with the determination of prognostic markers of disease progression. Materials and methods. A prospective cohort study of 347 patients with verified HIV infection and 78 healthy volunteers was conducted from January 2021 to December 2023. Taxonomic analysis of the microbiota was performed by high-throughput sequencing of the variable regions V3–V4 of the 16S rRNA gene on the Illumina MiSeq platform with determination of the viral load by PCR and counting of CD4-lymphocytes by flow cytometry. Results and discussion. A progressive decrease in microbial richness was revealed as HIV infection worsened, with a decrease in the Shannon index from 4.12±0.34 in the control to 1.94±0.29 at the terminal stage. A strong negative correlation was established between microbiota diversity and viral load, and a positive correlation with the number of CD4-cells. The relative representation of Proteobacteria increased from 8.1% to 41.7%, while the proportion of Firmicutes decreased from 68.4% to 34.2% with disease progression. Conclusions. The progression of HIV infection is naturally accompanied by the formation of severe dysbiosis with a critical decrease in microbial diversity at a CD4-cell level of less than 200/μl, which allows the use of microbiological parameters as additional prognostic biomarkers of the disease course.

About the Authors

L. N. Tuychiev
Tashkent State Medical University
Uzbekistan


Sh. B. Rakhmatullaeva
Tashkent State Medical University
Uzbekistan


K. P. Nasirova
Tashkent International University Kimyo
Russian Federation


B. S. Saidova
Urgench Medical Institute
Uzbekistan


References

1. Skopovets E.Ya., Belevtsev M.V. Changes in the intestinal microbiome in primary immunodeficiencies: a review of current data. Laboratory diagnostics. Eastern Europe. 2022. Vol. 11, No. 3, рp. 349–362 (In Russ.). doi: 10.34883/PI.2022.11.3.010. EDN ZEFWFK.

2. Goloshchapov O.V., Chukhlovin A.B., Glotov O.S. Possible role of intestinal human viruses and bacteriophages following hematopoietic stem cell transplantation: a mini-review // Cellular Therapy and Transplantation. 2021. Vol. 10, No. 4. P. 19–25. doi: 10.18620/ctt-1866-8836-2021-10-3-4-19-25. EDN CWOJBR.

3. Khasanova G.M., Urunova D.M., Akhmedzhanova Z.I., Giyasova G.M., Chernikova A.A., Khasanova A.N. Gastrointestinal tract damage in HIV infection. Perm Medical Journal, 2019. No. 3, рp. 24– 28 (In Russ.). doi: 10.17238/PmJ1609-1175.2019.3.24-28.

4. Khasanova G.R., Bikkinina O.I., Anokhin V.A., Anikhovskaya I.A., Yakovlev M.Yu. Intestinal factor of HIV infection progression. Advances in Modern Biology, 2020, Vol. 140, No. 3, рp. 278–288 (In Russ.). doi: 10.31857/S0042132420030059.

5. Altin K.H. Alteration of Gut microbiota during HIV infection // Bioengineering Studies. 2023. Vol. 4, No. 1. P. 9–15. doi: 10.37868/bes.v4i1.id247.

6. Guillo L., Uzzan M., Beaugerie L. et al. Impact of HIV Infection on the Course of Inflammatory Bowel Disease and Drug Safety Profile: A Multicenter GETAID Study // Clinical Gastroenterology and Hepatology. 2022. Vol. 20, Issue 4. P. 787–797. doi: 10.1016/j.cgh.2020.12.023.

7. Novikova V.P., Polunina A.V. Composition of intestinal microbiota in COVID infection (scientific review). Preventive and Clinical Medicine, 2020, No. 4 (77), рp. 81–86. EDN KTGSDF (In Russ.). doi: 10.47843/2074-9120_2020_4_81.

8. Asowata O.E., Singh A., Ngoepe A. et al. Irreversible depletion of intestinal CD4 T cells is associated with T cell activation during chronic HIV infection // JCI Insight. 2021. Vol. 6, No. 22. P. 1–18. doi: 10.1172/jci.insight.146162.

9. Crakes K.R., Jiang G. Gut Microbiome Alterations During HIV/SIV Infection: Implications for HIV Cure // Frontiers in Microbiology. 2019. Vol. 10. P. 1–10. doi: 10.3389/fmicb.2019.01104.

10. Kozorez E.I., Stoma I.O. Intestinal microbiome in HIV-infected patients. Clinical Infectology and Parasitology, 2024, Vol. 13, No. 3, рp. 348–358 (In Russ.). doi: 10.34883/PI.2024.13.3.037. EDN HVPLCK.

11. Narayanan A., Kieri O., Vesterbacka J. et al. Exploring the interplay between antiretroviral therapy and the gut-oral microbiome axis in people liv ing with HIV // Sci Rep. 2024. Vol. 14. Р. 17820. https://doi.org/10.1038/s41598-024-68479-4.


Review

For citations:


Tuychiev L.N., Rakhmatullaeva Sh.B., Nasirova K.P., Saidova B.S. Changes in intestinal flora depending on the stage of HIV infection, viral load and CD4-cell count. HIV Infection and Immunosuppressive Disorders. 2026;18(1):37-43. (In Russ.) https://doi.org/10.22328/2077-9828-2026-18-1-37-43

Views: 115

JATS XML


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2077-9828 (Print)